SmartSeq

Curated by Signal

Provider of next-generation sequencing(NGS) data analysis software

Overview

Provider of next-generation sequencing(NGS) data analysis software. The company offers software for the analysis, visualization, and prediction of genomic data. Product offering includes "Amplicon suite"-for the detection of genetic variants in human specimens, "SMARTVIR"- for analysis of drug-resistance mutations in HIV and HCV, "MICROBAT" and "COVID ANALYST".

Key facts

Founded: 2014
Headquarters: Novara, Italy
Stage: Sign up to view
Industry: Health Technology

Business model

14 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

OpenDoctor
Online medical training platform for healthcare professionals
Health TechnologyMilano, Italy
Mediatec
Digital practice management tool for providers
Health TechnologyLoreo, Italy
Cardioline
Portfolio of software and devices for cardiovascular conditions
Health TechnologyTrento, Italy

About SmartSeq

What does SmartSeq do?

Provider of next-generation sequencing(NGS) data analysis software.

Where is SmartSeq headquartered?

SmartSeq is headquartered in Novara, Italy.

When was SmartSeq founded?

SmartSeq was founded in 2014.

Which sector is SmartSeq in?

SmartSeq operates in Health Technology.

Who are SmartSeq's competitors?

Companies similar to SmartSeq include OpenDoctor, Mediatec, and Cardioline.